Abdel-Ghaffar Hala S, Abdel-Wahab Amani H, Roushdy Mohammed M, Osman Amira M M
Assiut University, Faculty of Medicine, Department of Anesthesia and Intensive Care, Assiut, Egito.
Assiut University, Faculty of Medicine, Department of Anesthesia and Intensive Care, Assiut, Egito.
Braz J Anesthesiol. 2019 Jul-Aug;69(4):350-357. doi: 10.1016/j.bjan.2019.03.007. Epub 2019 Jul 28.
The administration of ketamine as nebulized inhalation is relatively new and studies on nebulized ketamine are scarce. We aimed to investigate the analgesic efficacy of nebulized ketamine (1 and 2 mg.kg) administered 30 min before general anesthesia in children undergoing elective tonsillectomy in comparison with intravenous ketamine (0.5 mg.kg) and saline placebo.
One hundred children aged (7–12) years were randomly allocated in four groups ( = 25) receive; Saline Placebo (Group C), Intravenous Ketamine 0.5 mg.kg (Group K-IV), Nebulized Ketamine 1 mg.kg (Group K-N1) or 2 mg.kg (Group K-N2). The primary endpoint was the total consumption of rescue analgesics in the first 24 h postoperative.
The mean time to first request for rescue analgesics was prolonged in K-N1 (400.9 ± 60.5 min, 95% CI 375.9–425.87) and K-N2 (455.5 ± 44.6 min, 95% CI 437.1–473.9) groups compared with Group K-IV (318.5 ± 86.1 min, 95% CI 282.9–354.1) and Group C (68.3 ± 21.9 min, 95% CI 59.5–77.1; < 0.001), with a significant difference between K-N1 and K-N2 Groups ( < 0.001). The total consumption of IV paracetamol in the first 24 h postoperative was reduced in Group K-IV (672.6 ± 272.8 mg, 95% CI 559.9–785.2), Group K-N1 (715.6 ± 103.2 mg, 95% CI 590.4–840.8) and Group K-N2 (696.6 ± 133.3 mg, 95% CI 558.8–834.4) compared with Control Group (1153.8 ± 312.4 mg, 95% CI 1024.8–1282.8; < 0.001). With no difference between intravenous and Nebulized Ketamine Groups ( = 0.312). Patients in intravenous and Nebulized Ketamine Groups showed lower postoperative VRS scores compared with Group C ( < 0.001), no differences between K-IV, K-N1 or K-N2 group and without significant adverse effects.
Preemptive nebulized ketamine was effective for post-tonsillectomy pain relief. It can be considered as an effective alternative route to IV ketamine.
氯胺酮雾化吸入给药相对较新,关于雾化氯胺酮的研究较少。我们旨在研究在择期扁桃体切除术患儿全身麻醉前30分钟给予雾化氯胺酮(1毫克/千克和2毫克/千克)的镇痛效果,并与静脉注射氯胺酮(0.5毫克/千克)和生理盐水安慰剂进行比较。
100名年龄在7至12岁的儿童被随机分为四组(每组n = 25),分别接受:生理盐水安慰剂(C组)、静脉注射氯胺酮0.5毫克/千克(K-IV组)、雾化氯胺酮1毫克/千克(K-N1组)或2毫克/千克(K-N2组)。主要终点是术后24小时内急救镇痛药的总消耗量。
与K-IV组(318.5±86.1分钟,95%可信区间282.9 - 354.1)和C组(68.3±21.9分钟,95%可信区间59.5 - 77.1;P < 0.001)相比,K-N1组(400.9±60.5分钟,95%可信区间375.9 - 425.87)和K-N2组(455.5±44.6分钟,95%可信区间437.1 - 473.9)首次要求使用急救镇痛药的平均时间延长,K-N1组和K-N2组之间存在显著差异(P < 0.001)。术后24小时内静脉注射对乙酰氨基酚的总消耗量在K-IV组(672.6±272.8毫克,95%可信区间559.9 - 785.2)、K-N1组(715.6±103.2毫克,95%可信区间590.4 - 840.8)和K-N2组(696.6±133.3毫克,95%可信区间558.8 - 834.4)中均低于对照组(1153.8±312.4毫克,95%可信区间1024.8 - 1282.8;P < 0.001)。静脉注射氯胺酮组和雾化氯胺酮组之间无差异(P = 0.312)。静脉注射氯胺酮组和雾化氯胺酮组的患者术后视觉模拟评分(VRS)低于C组(P < 0.001),K-IV组、K-N1组或K-N2组之间无差异,且无明显不良反应。
预防性雾化氯胺酮对扁桃体切除术后疼痛缓解有效。它可被视为静脉注射氯胺酮的一种有效替代途径。